| Ticker Details |
Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$564.11B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.71 | 0.65%
|
| Avg Daily Range (30 D): |
$1.86 | 0.81%
|
| Avg Daily Range (90 D): |
$1.81 | 0.78%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
7.87M |
| Avg Daily Volume (30 D): |
5.44M |
| Avg Daily Volume (90 D): |
6.02M |
| Trade Size |
| Avg Trade Size (Sh.): |
132 |
| Avg Trade Size (Sh.) (30 D): |
36 |
| Avg Trade Size (Sh.) (90 D): |
38 |
| Institutional Trades |
| Total Institutional Trades: |
161,611 |
| Avg Institutional Trade: |
$8.64M |
| Avg Institutional Trade (30 D): |
$35.49M |
| Avg Institutional Trade (90 D): |
$34.82M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
28 |
| Market Closing Trades |
| Avg Closing Trade: |
$125.56M |
| Avg Closing Trade (30 D): |
$335.94M |
| Avg Closing Trade (90 D): |
$373.09M |
| Avg Closing Volume: |
945.37K |
|
|
| Financials |
| |
TTM |
Q4 2026 |
Q4 2025 |
|
Basic EPS
|
$8.73
|
$2.17
|
$2.12
|
|
Diluted EPS
|
$8.64
|
$2.14
|
$2.09
|
|
Revenue
|
$96.36B
|
$24.06B
|
$24.56B
|
|
Gross Profit
|
$65.36B
|
$15.96B
|
$16.6B
|
|
Net Income / Loss
|
$21.04B
|
$5.24B
|
$5.12B
|
|
Operating Income / Loss
|
$24.94B
|
$5.99B
|
$4.97B
|
|
Cost of Revenue
|
$31.01B
|
$8.11B
|
$7.97B
|
|
Net Cash Flow
|
$-16786M
|
$1.98B
|
$1.48B
|
|
PE Ratio
|
|
|
|
|
|
|
